Trial intelligence / Profile preview

HYR-PB21 for postoperative analgesia after unilateral hallux valgus osteotomy

ChiCTR2400091084Phase 2Not yet recruiting

Sponsor
Beijing Tongren Hospital
Start
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of HYR-PB21 in postoperative pain (3 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Area under the curve of pain rating score at rest (AUC0-72h). Planned start Oct 2024; status: not yet recruiting.

02

Drugs

HYR-PB21
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2400091084.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400091084.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call